Status:

COMPLETED

Cytosorb Therapy in Cardiac Surgery

Lead Sponsor:

University Hospital, Basel, Switzerland

Conditions:

Cardiopulmonary Surgery

Endocarditis

Eligibility:

All Genders

18+ years

Brief Summary

Cardiopulmonary surgery is associated with inflammatory responses that can lead to systemic inflammatory responses (SIRS), organ dysfunction (MOD) and death especially in patients with endocarditis. C...

Eligibility Criteria

Inclusion

  • patients with endocarditis undergoing cardiac surgery with cardio-pulmonary bypass circuit

Exclusion

  • denial of consent for data use

Key Trial Info

Start Date :

October 18 2019

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

December 4 2019

Estimated Enrollment :

249 Patients enrolled

Trial Details

Trial ID

NCT04309591

Start Date

October 18 2019

End Date

December 4 2019

Last Update

March 16 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Klinik für Herzchirurgie, Universitätsspital Basel

Basel, Switzerland, 4031